<!DOCTYPE html><html><head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
  </head>
  <body>
    <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal"><span style="font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black">Hello Labnetwork:</span></p>
    <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal"><span style="font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black"> </span></p>
    <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal"><span style="font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black">The recent discussion about PPE
        for lithography work seems an appropriate moment to present the
        findings of the TMAH Working Group.</span></p>
    <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal"><span style="font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black"><br>
        The TMAH Working Group is an informal ad-hoc group formed a
        couple of years ago amongst primarily academic nanofabrication
        facility folks concerned about students handling TMAH and the
        relatively poor awareness of its special hazards. As some of you
        will be aware, its primary hazard is associated not with its
        extremely corrosive nature, but rather with the fact that it is
        a potent neurotoxin, on par with HF but without any known
        antidote.<span style="mso-spacerun:yes">  </span>The goal of
        the TMAH Working Group was to find viable and less toxic
        alternatives to TMAH.<span style="mso-spacerun:yes">  </span>What
        follows is a summary of our findings. <br>
      </span></p>
    <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal"><span style="font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black"><br>
      </span><span style="font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman""></span></p>
    <p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal"><span style="font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black">TMAH is
        used in our labs primarily in 3 ways: </span><span style="font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman""></span></p>
    <ol type="1" start="1">
      <li class="MsoNormal" style="color:black;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l2 level1 lfo1;tab-stops:list .5in"><b style="mso-bidi-font-weight:normal"><span style="font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"">Developer for
            novolac photoresist</span></b><span style="font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">.
          The concentration is low (2.38% typically) and so the toxicity
          is lower than it is for full strength (25%).<span style="mso-spacerun:yes">  </span>There has been one
          fatality ascribed to an extensive exposure to 2.3% TMAH as
          well as other cases with less catastrophic outcomes.<span style="mso-spacerun:yes">  </span></span><span style="font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman""></span></li>
    </ol>
    <ol type="1" start="2">
      <li class="MsoNormal" style="color:black;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in"><b style="mso-bidi-font-weight:normal"><span style="font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"">Developer for
            HSQ-type e-beam resist</span></b><span style="font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"">. The
          concentration for this application is higher (25%) and the
          motivation to find an alternative is therefore greater. While
          relatively few substantial (greater than 5-7% of body area)
          exposures to 25% TMAH <span style="mso-spacerun:yes"> </span>have
          occurred, the current fatality rate seems to be around 75%.
          These findings are part of what inspired the IBM study
          mentioned in a recent labnetwork post.</span><span style="font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman""></span></li>
    </ol>
    <ol type="1" start="3">
      <li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l1 level1 lfo3;tab-stops:list .5in"><b style="mso-bidi-font-weight:normal"><span style="font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman";color:black">Etchant
            for Si</span></b><span style="font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     color:black">. The traditional etchant for this application is KOH,
          but for cases where metal ions are problematic, TMAH is the
          default. This application is the most hazardous as it
          typically requires larger volumes, longer times, and higher
          temperatures     </span><span style="font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman""></span><span style="font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black"></span><span style="font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black"></span><span style="font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black"></span></li>
    </ol>
    <span style="font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black">The
      TMAH Working Group has identified two primary chemical suppliers
      who have made an effort to develop and market TMAH-alternative
      quaternary ammonium salts<b style="mso-bidi-font-weight:normal">.
        SACHEM Chemical</b> is selling some more obvious alternatives
      like tetraethyl-, ethyltrimethyl-, and tetrabutyl-ammonium
      hydroxide under the brand NOVO-SAFE, distributed by Transene (</span><span style="font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman""><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__transene.com_tmah-2Dsubstitutes_&d=DwMF-g&c=WO-RGvefibhHBZq3fL85hQ&r=TEMLD8-VsxCGtcVzmvpT5GFNSczskEKHzW6aYlttmIY&m=byprFfYOOKk_Ho4LCBXGTSIneDLMb-MumT0G2i4B9pwQnqlo6887VnIvGL9YMrnu&s=fBK-owS68YfMmHfTua1jlFdSyGUYpOp1RsNNUHmtpwo&e="><span style="font-size:11.0pt;color:blue">https://transene.com/tmah-substitutes/</span></a></span><span style="font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
color:black">). <b style="mso-bidi-font-weight:normal">Huntsman
        Chemical</b> produces some more unconventional quaternary
      ammonium hydroxides like choline-OH and THEMAH (</span><span style="font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman""><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__www.huntsman.com_products_detail_550_tmah-2Dalternatives&d=DwMF-g&c=WO-RGvefibhHBZq3fL85hQ&r=TEMLD8-VsxCGtcVzmvpT5GFNSczskEKHzW6aYlttmIY&m=byprFfYOOKk_Ho4LCBXGTSIneDLMb-MumT0G2i4B9pwQnqlo6887VnIvGL9YMrnu&s=jOCJCGKlfcQRtfZS83iCQ_uiogAH7ceQkA_LFAZbBkM&e="><span style="font-size:11.0pt;color:blue">https://www.huntsman.com/products/detail/550/tmah-alternatives</span></a></span><span style="font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
color:black">). Several labs, including Queens Univeristy in Canada,
      Ohio State and Purdue, have tested products from both companies in
      standard tests for at least one of the applications above. There
      is quite a bit of data collected at this point, but the general
      observation is that all of the products tested are safer (in many
      cases dramatically safer) than TMAH and either equivalent or
      slightly slower than TMAH for etching and developing applications.
      <span style="mso-spacerun:yes"> </span>Further testing is required
      to determine the suitability of any given product for any given
      application, but we do have some general recommendations and
      confidence that something will work as long as you are willing to
      sacrifice some aspect of performance.</span><br>
    <p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal"><span style="font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black"><br>
      </span></p>
    <p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal"><span style="font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black">Here is
        summary of the work performed at Queens University by Graham
        Gibson:</span></p>
    <p class="MsoNormal"><b><span style="font-size:12.0pt;line-height:115%;font-family:
"Garamond","serif"">A systematic study was done at
          Queen’s University to characterize photoresist developing
          normally done by 2.38 wt% TMAH. A typical positive and
          negative Novolac-based photoresist were developed with TMAH
          and 8 other potential alternative quaternary ammonium
          hydroxide solutions, after screening out more than 10 others.
          Each UV-patterned sample was developed for a specific time,
          with the amount of resist dissolved measured by profilometry.
          At least 3 development times gives a linear plot, where the
          slope is the developing rate.</span></b></p>
    <p class="MsoNormal"><b><span style="font-size:12.0pt;line-height:115%;font-family:
"Garamond","serif"">Among the candidate quats were
          ETMAH and TEAH from SACHEM and Choline-OH and XHE-125 from
          Huntsman. The SACHEM products were purchased from Transene and
          the Huntsman products were obtained as samples from the
          manufacturer (note that XHE-125 is an experimental product not
          yet commercially available). Each candidate was prepared at 5
          different concentrations, each having a developing rate as
          described above.</span></b></p>
    <p class="MsoNormal"><b><span style="font-size:12.0pt;line-height:115%;font-family:
"Garamond","serif"">During screening, it was evident
          that some quats were not suitable developers, either because
          they were a poor solvent for the soluble part of the resist or
          too good a solvent for the insoluble part of the resist.</span></b></p>
    <p class="MsoNormal"><b><span style="font-size:12.0pt;line-height:115%;font-family:
"Garamond","serif"">In all cases, the standard TMAH
          developer was the fastest developer at a given wt%
          concentration. Based on the results, all the candidate
          developers in the full concentration study were able to
          develop the photoresist satisfactorily at some concentration.
          Focusing on the four highest performing candidates listed
          above, the concentration at which each had equivalent
          developing rate to 2.38% TMAH for the positive photoresist
          was:</span></b></p>
    <p class="MsoListParagraphCxSpFirst" style="text-indent:-.25in;mso-list:l3 level1 lfo4"><b><span style="font-size:12.0pt;line-height:107%;font-family:"Aptos","sans-serif";
mso-fareast-font-family:Aptos;mso-bidi-font-family:Aptos" lang="EN-CA"><span style="mso-list:Ignore">-<span style="font-style: normal; font-variant: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: "Times New Roman"; font-size-adjust: none; font-kerning: auto; font-language-override: normal; font-feature-settings: normal;">       
            </span></span></span><span style="font-size:12.0pt;
line-height:107%;font-family:"Garamond","serif"" lang="EN-CA">TMAH:<span style="mso-tab-count:
2">            </span>2.38%</span></b></p>
    <p class="MsoListParagraphCxSpMiddle" style="text-indent:-.25in;mso-list:l3 level1 lfo4"><b><span style="font-size:12.0pt;line-height:107%;font-family:"Aptos","sans-serif";
mso-fareast-font-family:Aptos;mso-bidi-font-family:Aptos" lang="EN-CA"><span style="mso-list:Ignore">-<span style="font-style: normal; font-variant: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: "Times New Roman"; font-size-adjust: none; font-kerning: auto; font-language-override: normal; font-feature-settings: normal;">       
            </span></span></span><span style="font-size:12.0pt;
line-height:107%;font-family:"Garamond","serif"" lang="EN-CA">ETMAH:<span style="mso-tab-count:
1">         </span>3.25%</span></b></p>
    <p class="MsoListParagraphCxSpMiddle" style="text-indent:-.25in;mso-list:l3 level1 lfo4"><b><span style="font-size:12.0pt;line-height:107%;font-family:"Aptos","sans-serif";
mso-fareast-font-family:Aptos;mso-bidi-font-family:Aptos" lang="EN-CA"><span style="mso-list:Ignore">-<span style="font-style: normal; font-variant: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: "Times New Roman"; font-size-adjust: none; font-kerning: auto; font-language-override: normal; font-feature-settings: normal;">       
            </span></span></span><span style="font-size:12.0pt;
line-height:107%;font-family:"Garamond","serif"" lang="EN-CA">Choline-OH:<span style="mso-tab-count:1">    </span>4.30%</span></b></p>
    <p class="MsoListParagraphCxSpMiddle" style="text-indent:-.25in;mso-list:l3 level1 lfo4"><b><span style="font-size:12.0pt;line-height:107%;font-family:"Aptos","sans-serif";
mso-fareast-font-family:Aptos;mso-bidi-font-family:Aptos" lang="EN-CA"><span style="mso-list:Ignore">-<span style="font-style: normal; font-variant: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: "Times New Roman"; font-size-adjust: none; font-kerning: auto; font-language-override: normal; font-feature-settings: normal;">       
            </span></span></span><span style="font-size:12.0pt;
line-height:107%;font-family:"Garamond","serif"" lang="EN-CA">XHE-125: <span style="mso-spacerun:yes"> </span><span style="mso-tab-count:1">      </span>5.70%</span></b></p>
    <p class="MsoListParagraphCxSpLast" style="text-indent:-.25in;mso-list:l3 level1 lfo4"><b><span style="font-size:12.0pt;line-height:107%;font-family:"Aptos","sans-serif";
mso-fareast-font-family:Aptos;mso-bidi-font-family:Aptos" lang="EN-CA"><span style="mso-list:Ignore">-<span style="font-style: normal; font-variant: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: "Times New Roman"; font-size-adjust: none; font-kerning: auto; font-language-override: normal; font-feature-settings: normal;">       
            </span></span></span><span style="font-size:12.0pt;
line-height:107%;font-family:"Garamond","serif"" lang="EN-CA">TEAH: <span style="mso-tab-count:
2">           </span>7.50%</span></b></p>
    <p class="MsoNormal"><b><span style="font-size:12.0pt;line-height:115%;font-family:
"Garamond","serif"">The selectivity of TMAH was also
          better than any of the candidates, although all the above 4
          candidates still had good selectivity. The relative erosion
          rate (rate of loss of insoluble resist divided by developing
          rate) for these candidates for the positive resist at the
          concentration of equivalence were as follows (all
          selectivities were better for the negative resist):</span></b></p>
    <p class="MsoListParagraphCxSpFirst" style="text-indent:-.25in;mso-list:l3 level1 lfo4"><b><span style="font-size:12.0pt;line-height:107%;font-family:"Aptos","sans-serif";
mso-fareast-font-family:Aptos;mso-bidi-font-family:Aptos" lang="EN-CA"><span style="mso-list:Ignore">-<span style="font-style: normal; font-variant: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: "Times New Roman"; font-size-adjust: none; font-kerning: auto; font-language-override: normal; font-feature-settings: normal;">       
            </span></span></span><span style="font-size:12.0pt;
line-height:107%;font-family:"Garamond","serif"" lang="EN-CA">TMAH: <span style="mso-tab-count:
1">           </span>0.003</span></b></p>
    <p class="MsoListParagraphCxSpMiddle" style="text-indent:-.25in;mso-list:l3 level1 lfo4"><b><span style="font-size:12.0pt;line-height:107%;font-family:"Aptos","sans-serif";
mso-fareast-font-family:Aptos;mso-bidi-font-family:Aptos" lang="EN-CA"><span style="mso-list:Ignore">-<span style="font-style: normal; font-variant: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: "Times New Roman"; font-size-adjust: none; font-kerning: auto; font-language-override: normal; font-feature-settings: normal;">       
            </span></span></span><span style="font-size:12.0pt;
line-height:107%;font-family:"Garamond","serif"" lang="EN-CA">XHE-125:<span style="mso-tab-count:1">        </span>0.007</span></b></p>
    <p class="MsoListParagraphCxSpMiddle" style="text-indent:-.25in;mso-list:l3 level1 lfo4"><b><span style="font-size:12.0pt;line-height:107%;font-family:"Aptos","sans-serif";
mso-fareast-font-family:Aptos;mso-bidi-font-family:Aptos" lang="EN-CA"><span style="mso-list:Ignore">-<span style="font-style: normal; font-variant: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: "Times New Roman"; font-size-adjust: none; font-kerning: auto; font-language-override: normal; font-feature-settings: normal;">       
            </span></span></span><span style="font-size:12.0pt;
line-height:107%;font-family:"Garamond","serif"" lang="EN-CA">ETMAH: <span style="mso-tab-count:
1">        </span>0.007</span></b></p>
    <p class="MsoListParagraphCxSpMiddle" style="text-indent:-.25in;mso-list:l3 level1 lfo4"><b><span style="font-size:12.0pt;line-height:107%;font-family:"Aptos","sans-serif";
mso-fareast-font-family:Aptos;mso-bidi-font-family:Aptos" lang="EN-CA"><span style="mso-list:Ignore">-<span style="font-style: normal; font-variant: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: "Times New Roman"; font-size-adjust: none; font-kerning: auto; font-language-override: normal; font-feature-settings: normal;">       
            </span></span></span><span style="font-size:12.0pt;
line-height:107%;font-family:"Garamond","serif"" lang="EN-CA">TEAH:<span style="mso-tab-count:
2">            </span>0.017</span></b></p>
    <p class="MsoListParagraphCxSpLast" style="text-indent:-.25in;mso-list:l3 level1 lfo4"><b><span style="font-size:12.0pt;line-height:107%;font-family:"Aptos","sans-serif";
mso-fareast-font-family:Aptos;mso-bidi-font-family:Aptos" lang="EN-CA"><span style="mso-list:Ignore">-<span style="font-style: normal; font-variant: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: "Times New Roman"; font-size-adjust: none; font-kerning: auto; font-language-override: normal; font-feature-settings: normal;">       
            </span></span></span><span style="font-size:12.0pt;
line-height:107%;font-family:"Garamond","serif"" lang="EN-CA">Choline-OH:<span style="mso-tab-count:1">    </span>0.022</span></b></p>
    <p class="MsoNormal"><b><span style="font-size:12.0pt;line-height:115%;font-family:
"Garamond","serif"">Effectively, then, a lab could
          use any one of these quats at the concentration indicated as a
          replacement for 2.38% TMAH with some success. The exact
          equivalent concentration depends on the resist, so some
          experimentation is required.</span></b></p>
    <p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal"><span style="font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black">Here is
        a link to an abstract regarding work done at Ohio State and
        Purdue on  Novosafe Developer SE-44-26 and Novosafe SE-44 from
        Transene:   <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__eipbn.org_abstracts_2024_papers_9A-2D3.pdf&d=DwMFAw&c=WO-RGvefibhHBZq3fL85hQ&r=TEMLD8-VsxCGtcVzmvpT5GFNSczskEKHzW6aYlttmIY&m=1_54H_dFFYNv-wcmLpnX3rpvsgl5GrSCHKKSuBptlAD_JLPboiw9os5SiHW9-I43&s=rRzF1J0kBIyVqCC3oyl_AYzFIyaOJfOqiGCKaIUwarA&e="><span style="color:blue">https://urldefense.proofpoint.com/v2/url?u=https-3A__eipbn.org_abstracts_2024_papers_9A-2D3.pdf&d=DwMFAw&c=WO-RGvefibhHBZq3fL85hQ&r=TEMLD8-VsxCGtcVzmvpT5GFNSczskEKHzW6aYlttmIY&m=1_54H_dFFYNv-wcmLpnX3rpvsgl5GrSCHKKSuBptlAD_JLPboiw9os5SiHW9-I43&s=rRzF1J0kBIyVqCC3oyl_AYzFIyaOJfOqiGCKaIUwarA&e=</span></a></span><span style="font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman""></span></p>
    <p class="MsoNormal"><span style="font-family:"Times New Roman","serif""><br>
      </span></p>
    <p class="MsoNormal"><span style="font-family:"Times New Roman","serif"">We
        welcome your thoughts and comments.<span style="mso-spacerun:yes">  </span>Thanks to all 20 members of
        the TMAH Working Group, who have offered lots of hard work and
        thoughtful discussion to the rendering of these findings. </span></p>
    <p class="MsoNormal"><span style="font-family:"Times New Roman","serif""> </span></p>
    <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal"><span style="font-family:"Times New Roman","serif"">Mac
        Hathaway <span style="mso-tab-count:1"> </span><span style="mso-tab-count:1">            </span>Center for
        Nanoscale System - Harvard University</span></p>
    <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal"><span style="font-family:"Times New Roman","serif"">Aimee
        Price <span style="mso-spacerun:yes"> </span><span style="mso-tab-count:1">    </span><span style="mso-spacerun:yes"> </span><span style="mso-tab-count:1">         
        </span>Institute for Materials and Manufacturing Research - The
        Ohio State University</span></p>
    <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal"><span style="font-family:"Times New Roman","serif"">Dave
        Hollingshead<span style="mso-tab-count:1">      </span>Institute
        for Materials and Manufacturing Research - The Ohio State
        University</span></p>
    <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal"><span style="font-family:"Times New Roman","serif"">Graham
        Gibson <span style="mso-spacerun:yes"> </span><span style="mso-tab-count:1">         </span>NanoFabrication
        Kingston  - Queens University</span></p>
    <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal"><span style="font-family:"Times New Roman","serif"">Justin
        Wirth <span style="mso-tab-count:1">    </span><span style="mso-tab-count:1">            </span>Birck
        Nanotechnology Center - Purdue University</span></p>
    <div class="moz-signature"><span style="font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif""><o:p></o:p></span>
      <div class="WordSection1">
        <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal"><span style="font-size:12.0pt;font-family:"Times New Roman","serif""><o:p> </o:p></span></p>
      </div>
    </div>
  </body>
</html>